oneplacenewsSource: ScienceDaily Health
Summary
A new study indicates that glucosamine, a widely-used joint supplement, may accelerate the progression from mild cognitive impairment to Alzheimer’s disease. The research shows a 25% increased risk of dementia among glucosamine users, alongside potential biological explanations for this link.
Why It Matters
This finding raises significant concerns about the safety of glucosamine, a supplement many consider harmless. As the aging population grows, understanding risks associated with commonly used substances becomes increasingly crucial for health guidance and policy. Further research could lead to reevaluating recommendations on glucosamine and its potential impact on cognitive health.
